SARS-CoV-2,西

Haruaki Nobori1, Keiko Baba1, Takayuki Kuroda1

  • 1Pharmaceutical Research Division, Shionogi & Co., Ltd., 1-1, Futaba-cho 3-chome, Toyonaka, Osaka, 561-0825, Japan.

Antiviral research
|March 1, 2024
PubMed
概括

口服抗病毒药物恩西特里尔维尔在预防性给予老鼠时,显著保护老鼠免受致命的SARS-CoV-2感染. 这种抗病毒药物在高危人群中显示出预防COVID-19的前景.